|
［1］Lu ChCh, Huang YY, XU LY, et al.
Up-regulation of serine protease inhibitor Kazal type 1 expression in human
lung adenocarcinoma and promotion of proliferation of cancer cells ［J］. Acta Anatomica Sinica, 2019,
50(2):192-200. (in Chinese)
陆畅畅，黄燕燕，续力云，等. 丝氨酸蛋白酶抑制因子Kazal 1型在人肺腺癌组织表达上调并促进肺腺癌细胞的增殖［J］. 解剖学报，2019，50(2)：192-200.
［2］Li F,
Liu T, Xiao CY, et al. FOXP1 and SPINK1 reflect the risk of cirrhosis
progression to HCC with HBV infection ［J］. Biomed Pharmacother, 2015, 72:103-108.
［3］Hass
HG, Jobst J, Vogel U, et al. Overexpression of tumor-associated trypsin
inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma:
potential implications for viral hepatocarcinogenesis ［J］. Oncol Res Treat, 2014, 37(12):732-738.
［4］Chen W,
Zheng R, Baade PD, et al. Cancer statistics in China, 2015 ［J］. CA Cancer J Clin, 2016, 66(2):115-132.
［5］Rasanen
K, Itkonen O, Koistinen H, et al. Emerging roles of SPINK1 in cancer［J］. Clin Chem, 2016, 62(3):449-457.
［6］Xia C,
Dong X, Li H, et al. Cancer statistics in China and United States, 2022:
profiles, trends, and determinants［J］. Chin Med J (Engl), 2022, 135(5):584-590.
［7］Zhu C,
Han H, Li J, et al. Hepatitis B virus X protein induced
serine protease inhibitor kazal type 1 is associated with the progression of
HBV-related diseases［J］. Biomed
Res Int, 2019, 2019:9321494.
［8］Huang
K, Xie W, Wang S, et al. High SPINK1 expression predicts poor prognosis and
promotes cell proliferation and metastasis of hepatocellular carcinoma ［J］. J Invest Surg, 2021, 34(9):1011-1020.
［9］Mehner
C, Radisky ES. Bad tumors made worse: SPINK1 ［J］. Front Cell Dev Biol, 2019, 7:10.
［10］Lin S,
Lin Y, Wu Z, et al. circRPS16 promotes proliferation and invasion of
hepatocellular carcinoma by sponging miR-876-5p to upregulate SPINK1 ［J］. Front Oncol, 2021, 11:724415.
［11］Guo M,
Zhou X, Han X, et al. SPINK1 is a prognosis predicting factor of non-small cell
lung cancer and regulates redox homeostasis ［J］. Oncol Lett, 2019, 18(6):6899-6908.
［12］Chang
C, Zhao W, Luo Y, et al. Serine peptidase inhibitor Kazal type I (SPINK1)
promotes BRL-3A cell proliferation via p38, ERK, and JNK pathways ［J］. Cell Biochem Funct, 2017, 35(6):339-348.
［13］Wang
LL, Luo J, He ZH, et al. STEAP3 promotes cancer cell proliferation by
facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-STAT3 signaling in
hepatocellular carcinoma［J］.
Cell Death Dis, 2021, 12(11):1052.
［14］Kim H,
Lim HY. Novel EGFR-TK inhibitor EKB-569 inhibits hepatocellular carcinoma cell
proliferation by AKT and MAPK pathways［J］. J Korean Med Sci, 2011, 26(12):1563-1568.
［15］Kannangai
R, Sahin F, Torbenson MS. EGFR is phosphorylated at Ty845 in hepatocellular
carcinoma ［J］. Mod Pathol,
2006, 19(11):1456-1461.
［16］Yamada
K, Kizawa R, Yoshida A, et al. Extracellular PKCdelta signals to epidermal
growth factor receptor for tumor proliferation in liver cancer cells ［J］. Cancer Sci, 2022, 113(7):2378-2385.
［17］Chang
CF, Yang J, Li XF, et al. SPINK3: A novel growth factor that promotes rat liver
regeneration［J］. Mol Biol
(Mosk), 2016, 50(3):457-465.
［18］Zhang
Z, Pan Y, Zhao Y, et al. Delphinidin modulates JAK/STAT3 and MAPKinase
signaling to induce apoptosis in HCT116 cells［J］. Environ Toxicol, 2021, 36(8):1557-1566.
［19］Okabe
N, Fujiwara M, Tachibana K, et al. STAT3 activation in thymic epithelial
tumors: correlation with cyclin D1, JAK3, and clinical behavior［J］. Gen Thorac Cardiovasc Surg, 2021,
69(11):1482-1491.
［20］Huth HW, Albarnaz JD, Torres AA, et al.
MEK2 controls the activation of MKK3/MKK6-p38 axis involved in the MDA-MB-231
breast cancer cell survival: Correlation with cyclin D1 expression［J］. Cell Signal, 2016, 28(9):1283-1291.
|
